4
Changes in Ownership
GeneDx Holdings Corp. Filed Acc 0001689575-26-000030
CHIEF EXECUTIVE OFFICER sold 3,692 shares at $84.22 ($310,932)
- CHIEF EXECUTIVE OFFICER acquired 6,547 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2026-09-09 | Option exercise | +6,547 | 110,919 | D | ||
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2026-09-09 | Sale | −3,692 | $84.22 | $310,932 | 107,227 | D |
| Derivatives | |||||||
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2026-09-09 | Option exercise · Restricted Stock Unit | −6,547 | 6,547 | D | ||
| Open-market sales · 3,692 sh · avg $84.22 · $310,932 | |||||||
Loading xslF345X06/form4-09112026_080931.xml…